Diabetes News and Resources

‍Vertex Pharmaceuticals and Lonza have recently announced a strategic collaboration aimed at supporting the manufacturing of Vertex’s portfolio of investigational stem cell-derived, fully differentiated insulin-producing islet cell therapies for people with Type 1 Diabetes. The 130,000ft² site will be run